Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Boost Device Training in Interstitial Lung Disease
NCT06991153Completed
- Sponsor
- Cairo University
- Start
- May 2025
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Cairo University. Primary endpoints: Forced Vital Capacity at 8 weeks, Forced Expiratory Volume in 1 Second at 8 weeks and 2 more. Started May 2025; status: completed.
Beyond the preview
Go deeper on NCT06991153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06991153.